Answering questions from the Biotech Mailbag on FLXN and SGYP.
This trading approach limits emotions and risks.
At stake is whether the Republicans can work out their differences.
Emotion of yesterday's collapse is pretty much gone.
But what will be most important is whether support stays strong and the buyers show interest in the afternoon.
Why not buy something and try to make some money rather than waste time predicting how this will all come to an ugly end?
More gains await patient CLVS holders.
Biotech has a base pattern than can support a lot more upside..
We are not going to be shaken out of this lethargy until we have a little drama.
Biotech companies show more energy than the rest of the market Monday.

Columnist Conversations

Shares of Coach appear to be back in rally mode today. The stock is up over 2.25%(Kate Spade deal?)and is one ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.